Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
10021 (44) 44
peripheral vascular disease (38) 38
index medicus (33) 33
humans (27) 27
female (23) 23
male (22) 22
middle aged (20) 20
cardiac & cardiovascular systems (19) 19
aged (18) 18
original (16) 16
original s (13) 13
adult (12) 12
treatment outcome (12) 12
abridged index medicus (10) 10
original contributions (10) 10
10178 (9) 9
clinical neurology (9) 9
double-blind method (9) 9
research (9) 9
stroke (9) 9
10058 (8) 8
prospective studies (8) 8
10034 (7) 7
10111 (7) 7
hypertension (7) 7
analysis (6) 6
blood pressure (6) 6
disease (6) 6
risk factors (6) 6
aged, 80 and over (5) 5
cardiovascular diseases (5) 5
clinical sciences (5) 5
clinical trial (5) 5
double-blind (5) 5
follow-up studies (5) 5
original articles (5) 5
outcomes (5) 5
risk (5) 5
safety (5) 5
10062 (4) 4
10084 (4) 4
10094 (4) 4
10195 (4) 4
care and treatment (4) 4
drug therapy (4) 4
heart failure (4) 4
hematology (4) 4
lipoproteins (4) 4
metaanalysis (4) 4
mortality (4) 4
original research articles (4) 4
randomized controlled trial (4) 4
severity of illness index (4) 4
single-blind method (4) 4
time factors (4) 4
10041 (3) 3
10072 (3) 3
10090 (3) 3
10150 (3) 3
10173 (3) 3
10177 (3) 3
10188 (3) 3
10191 (3) 3
acute coronary syndrome (3) 3
animals (3) 3
diagnosis (3) 3
efficacy (3) 3
heart (3) 3
high-risk (3) 3
hypercholesterolemia (3) 3
journal article (3) 3
ldl cholesterol (3) 3
management (3) 3
paclitaxel (3) 3
pcsk9 (3) 3
peripheral artery disease (3) 3
pregnancy (3) 3
registries (3) 3
stroke - drug therapy (3) 3
stroke - epidemiology (3) 3
therapy (3) 3
usage (3) 3
10015 (2) 2
10029 (2) 2
10035 (2) 2
10036 (2) 2
10042 (2) 2
10053 (2) 2
10068 (2) 2
10071 (2) 2
10110 (2) 2
10112 (2) 2
10161 (2) 2
10176 (2) 2
10189 (2) 2
acute ischemic-stroke (2) 2
adolescent (2) 2
alirocumab (2) 2
anacetrapib (2) 2
angioplasty (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
by Mahaffey, Kenneth W and Neal, Bruce and Perkovic, Vlado and de Zeeuw, Dick and Fulcher, Greg and Erondu, Ngozi and Shaw, Wayne and Fabbrini, Elisa and Sun, Tao and Li, Qiang and Desai, Mehul and Matthews, David R and CANVAS Program Collaborative Grp and CANVAS Program Collaborative Group
Circulation, ISSN 0009-7322, 01/2018, Volume 137, Issue 4, pp. 323 - 334
Background: Canagliflozin is a sodium glucose cotransporter 2 inhibitor that significantly reduces the composite of cardiovascular death, nonfatal myocardial... 
clinical trial | DESIGN | secondary prevention | RATIONALE | SAFETY | canagliflozin | DISEASE | primary prevention | diabetes mellitus | PLACEBO-CONTROLLED TRIAL | OUTCOMES | BASE-LINE CHARACTERISTICS | CARDIAC & CARDIOVASCULAR SYSTEMS | PERIPHERAL VASCULAR DISEASE | Type 2 diabetes | Research | Cardiovascular diseases | Drug therapy | Risk factors | 10021 | Original s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
by Chan, Dick C and Watts, Gerald F and Somaratne, Ransi and Wasserman, Scott M and Scott, Rob and Barrett, P. Hugh R
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2018, Volume 38, Issue 7, pp. 1644 - 1655
OBJECTIVE—Inhibition of PCSK9 (proprotein convertase subtilisin/kexin type 9) and statins are known to lower plasma LDL (low-density lipoprotein)-cholesterol... 
leucine | 10071 | Clinical and Population Studies | 10021 | mass spectrometry | fasting | 10034 | triglycerides | 10036 | 10058 | lipoproteins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial
by Bath, Philip M and Woodhouse, Lisa J and Krishnan, Kailash and Appleton, Jason P and Anderson, Craig S and Berge, Eivind and Cala, Lesley and Dixon, Mark and England, Timothy J and Godolphin, Peter J and Hepburn, Trish and Mair, Grant and Montgomery, Alan A and Phillips, Stephen J and Potter, John and Price, Chris I and Randall, Marc and Robinson, Thompson G and Roffe, Christine and Rothwell, Peter M and Sandset, Else C and Sanossian, Nerses and Saver, Jeffrey L and Siriwardena, A Niroshan and Venables, Graham and Wardlaw, Joanna M and Sprigg, Nikola and on behalf of the RIGHT-2 Investigators
Stroke, ISSN 0039-2499, 11/2019, Volume 50, Issue 11, pp. 3064 - 3071
BACKGROUND AND PURPOSE—Pilot trials suggest that glyceryl trinitrate (GTN; nitroglycerin) may improve outcome when administered early after stroke onset.... 
blood pressure | nitroglycerin | Original Contributions | 10173 | allied health personnel | 10110 | 10176 | 10021 | 10177 | humans | ambulances
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Interhospital Transfer Before Thrombectomy Is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke)
by Froehler, Michael T and Saver, Jeffrey L and Zaidat, Osama O and Jahan, Reza and Aziz-Sultan, Mohammad Ali and Klucznik, Richard P and Haussen, Diogo C and Hellinger, Frank R and Yavagal, Dileep R and Yao, Tom L and Liebeskind, David S and Jadhav, Ashutosh P and Gupta, Rishi and Hassan, Ameer E and Martin, Coleman O and Bozorgchami, Hormozd and Kaushal, Ritesh and Nogueira, Raul G and Gandhi, Ravi H and Peterson, Eric C and Dashti, Shervin R and Given, Curtis A and Mehta, Brijesh P and Deshmukh, Vivek and Starkman, Sidney and Linfante, Italo and McPherson, Scott H and Kvamme, Peter and Grobelny, Thomas J and Hussain, Muhammad S and Thacker, Ike and Vora, Nirav and Chen, Peng Roc and Monteith, Stephen J and Ecker, Robert D and Schirmer, Clemens M and Sauvageau, Eric and Abou-Chebl, Alex and Derdeyn, Colin P and Maidan, Lucian and Badruddin, Aamir and Siddiqui, Adnan H and Dumont, Travis M and Alhajeri, Abdulnasser and Taqi, M Asif and Asi, Khaled and Carpenter, Jeffrey and Boulos, Alan and Jindal, Gaurav and Puri, Ajit S and Chitale, Rohan and Deshaies, Eric M and Robinson, David H and Kallmes, David F and Baxter, Blaise W and Jumaa, Mouhammad A and Sunenshine, Peter and Majjhoo, Aniel and English, Joey D and Suzuki, Shuichi and Fessler, Richard D and Delgado Almandoz, Josser E and Martin, Jerry C and Mueller-Kronast, Nils H and STRATIS Investigators
Circulation, ISSN 0009-7322, 12/2017, Volume 136, Issue 24, pp. 2311 - 2321
BACKGROUND:Endovascular treatment with mechanical thrombectomy (MT) is beneficial for patients with acute stroke suffering a large-vessel occlusion, although... 
emergency medical services | stent retriever | systems of care | endovascular treatment | ischemic stroke | INTRAVENOUS T-PA | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY | RANDOMIZED CONTROLLED-TRIAL | MECHANICAL THROMBECTOMY | CARE | ENDOVASCULAR THERAPY | HEART | IMPROVEMENT | PERIPHERAL VASCULAR DISEASE | GUIDELINES-STROKE | CLINICAL-OUTCOMES | Prospective Studies | Ischemia - epidemiology | Humans | Endovascular Procedures | Treatment Outcome | Ischemia - mortality | Stroke - surgery | Thrombectomy | Hospitals | Time Factors | Survival Analysis | Ischemia - surgery | Registries | Stroke - epidemiology | Patient Transfer - statistics & numerical data | Stroke - mortality | 10021 | 10178 | Original s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction
by Ellingsen, Øyvind and Halle, Martin and Conraads, Viviane and Støylen, Asbjørn and Dalen, Håvard and Delagardelle, Charles and Larsen, Alf-Inge and Hole, Torstein and Mezzani, Alessandro and Van Craenenbroeck, Emeline M and Videm, Vibeke and Beckers, Paul and Christle, Jeffrey W and Winzer, Ephraim and Mangner, Norman and Woitek, Felix and Höllriegel, Robert and Pressler, Axel and Monk-Hansen, Tea and Snoer, Martin and Feiereisen, Patrick and Valborgland, Torstein and Kjekshus, John and Hambrecht, Rainer and Gielen, Stephan and Karlsen, Trine and Prescott, Eva and Linke, Axel and SMARTEX Heart Failure Study and SMARTEX Heart Failure Study (Study of Myocardial Recovery After Exercise Training in Heart Failure) Group
Circulation, ISSN 0009-7322, 02/2017, Volume 135, Issue 9, pp. 839 - 849
BACKGROUND:Small studies have suggested that high-intensity interval training (HIIT) is superior to moderate continuous training (MCT) in reversing cardiac... 
heart failure | exercise | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | DISEASE | SUPERIOR | PERIPHERAL VASCULAR DISEASE | EXERCISE CAPACITY | AEROBIC EXERCISE | Echocardiography | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Heart Ventricles - diagnostic imaging | High-Intensity Interval Training | Exercise Test | Ventricular Remodeling | Exercise Tolerance | Heart Rate - physiology | Quality of Life | Female | Aged | Heart Failure - diagnosis | Heart failure | Care and treatment | Cardiac output | Health aspects | Analysis | Aerobic exercises | 10094 | 10063 | 10021 | 10101 | Original s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
by Dake, Michael D and Ansel, Gary M and Jaff, Michael R and Ohki, Takao and Saxon, Richard R and Smouse, H Bob and Machan, Lindsay S and Snyder, Scott A and O’Leary, Erin E and Ragheb, Anthony O and Zeller, Thomas and Zilver PTX Investigators
Circulation, ISSN 0009-7322, 04/2016, Volume 133, Issue 15, pp. 1472 - 1483
BACKGROUND—This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal... 
paclitaxel | drug-eluting stents | peripheral artery disease | stents | angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | OCCLUSIVE DISEASE | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | POPLITEAL ARTERIES | FOLLOW-UP | LESIONS | BARE NITINOL STENT | COATED BALLOON | SUPERFICIAL FEMORAL-ARTERY | BALLOON ANGIOPLASTY | PERIPHERAL VASCULAR DISEASE | QUALITY-OF-LIFE | Recurrence | Follow-Up Studies | Ticlopidine - therapeutic use | Angioplasty | Humans | Middle Aged | Male | Popliteal Artery - drug effects | Adult | Female | Aspirin - therapeutic use | Intermittent Claudication - therapy | Paclitaxel - administration & dosage | Stents | Drug-Eluting Stents | Ischemia - therapy | Anticoagulants - therapeutic use | Combined Modality Therapy | Femoral Artery - drug effects | Paclitaxel - therapeutic use | Disease Progression | Ticlopidine - analogs & derivatives | Disease-Free Survival | Arterial Occlusive Diseases - drug therapy | Clopidogrel | Ischemia - surgery | Aged | Arterial Occlusive Diseases - therapy | Equipment Failure | Vascular Patency | Transluminal angioplasty | Drug-eluting stents | Paclitaxel | Dosage and administration | Research | Comparative analysis | Peripheral vascular diseases | 10192 | 10191 | 10143 | 10021 | 10188 | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans
by Reyes-Soffer, Gissette and Pavlyha, Marianna and Ngai, Colleen and Thomas, Tiffany and Holleran, Stephen and Ramakrishnan, Rajasekhar and Karmally, Wahida and Nandakumar, Renu and Fontanez, Nelson and Obunike, Joseph and Marcovina, Santica M and Lichtenstein, Alice H and Matthan, Nirupa R and Matta, James and Maroccia, Magali and Becue, Frederic and Poitiers, Franck and Swanson, Brian and Cowan, Lisa and Sasiela, William J and Surks, Howard K and Ginsberg, Henry N
Circulation, ISSN 0009-7322, 01/2017, Volume 135, Issue 4, pp. 352 - 362
BACKGROUND:Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9), lowers plasma low-density lipoprotein (LDL) cholesterol... 
PCSK9 | apoliprotein | lipoproteins | Lp(a) | LDL receptor | low-density lipoprotein | CONTROLLED-TRIAL | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | LOW-DENSITY-LIPOPROTEIN | PLASMA LIPOPROTEIN(A) | SUBTILISIN/KEXIN TYPE 9 | VERY-LOW-DENSITY | APOLIPOPROTEIN-B | LDL CHOLESTEROL | PERIPHERAL VASCULAR DISEASE | TYPE-2 DIABETES-MELLITUS | Young Adult | Proprotein Convertase 9 - antagonists & inhibitors | Antibodies, Monoclonal - administration & dosage | Humans | Lipoproteins, VLDL - metabolism | Middle Aged | Adolescent | Adult | Female | Male | Aged | Healthy Volunteers | Proteolipids | Lipoproteins | Research | Blood lipoproteins | Low density lipoproteins | Analysis | 10195 | 10021 | 10035 | 10034 | 10036 | Original s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
by Ho, C.Y and Day, S.M and Ashley, E.A and Michels, Michelle and Pereira, A.C and Jacoby, D and Cirino, A.L and Fox, J.C and Lakdawala, N.K and Ware, J.S and Caleshu, C.A and Helms, A.S and Colan, Steven and Girolami, F and Cecchi, F and Seidman, Christine and Sajeev, G and Signorovitch, J and Green, E.M and Olivotto, Iacopo and SHaRe Investigators and For the SHaRe Investigators
Circulation (Baltimore), ISSN 0009-7322, 10/2018, Volume 138, Issue 14, pp. 1387 - 1398
markdownabstractBackground: A better understanding of the factors that contribute to heterogeneous outcomes and lifetime disease burden in hypertrophic... 
Genetics | Risk | Registry | Natural history | Hypertrophic Cardiomyopathy | Cardiomyopathy | Hypertrophic | Registries | hypertrophic | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOLOGY | GUIDELINES | AMERICAN-COLLEGE | registries | natural history | PHENOTYPE ASSOCIATIONS | genetics | HEART-ASSOCIATION | SUDDEN CARDIAC DEATH | PERIPHERAL VASCULAR DISEASE | risk | MUTATIONS | cardiomyopathy | LOW CARDIOVASCULAR MORTALITY | CONTEMPORARY MANAGEMENT STRATEGIES | Care and treatment | Usage | Cardiomyopathy, Hypertrophic | Gene mutations | Genotype | Genetic aspects | Research | Diagnosis | Implantable cardioverter-defibrillators | 10090 | 10084 | 10095 | 10094 | cardiomyopathy, hypertrophic | 10021 | Original s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
by Steg, Philippe Gabriel and Szarek, Michael and Bhatt, Deepak L and Bittner, Vera A and Brégeault, Marie-France and Dalby, Anthony J and Diaz, Rafael and Edelberg, Jay M and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Lecorps, Guillaume and Mahaffey, Kenneth W and Moryusef, Angèle and Ostadal, Petr and Parkhomenko, Alexander and Pordy, Robert and Roe, Matthew T and Tricoci, Pierluigi and Vogel, Robert and White, Harvey D and Zeiher, Andreas M and Schwartz, Gregory G and ODYSSEY OUTCOMES Comm and ODYSSEY OUTCOMES Committees and Investigators and For the ODYSSEY OUTCOMES Committees and Investigators
Circulation, ISSN 0009-7322, 07/2019, Volume 140, Issue 2, pp. 103 - 112
BACKGROUND:Previous trials of PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitors demonstrated reductions in major adverse cardiovascular events,... 
PCSK9 protein | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | alirocumab | PCSK9 | MONOCLONAL-ANTIBODY | acute coronary syndrome | REDUCING LIPIDS | mortality | cholesterol | PERIPHERAL VASCULAR DISEASE | EVOLOCUMAB | Acute coronary syndrome | Drug therapy | Patient outcomes | 10161 | 10072 | 10021 | 10034 | Original s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors
by Scheen, André J
Circulation Research, ISSN 0009-7330, 05/2018, Volume 122, Issue 10, pp. 1439 - 1459
Cardiovascular disease (CVD) is a major challenge in the management of type 2 diabetes mellitus. Glucose-lowering agents that reduce the risk of major... 
empagliflozin | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | REDUCING BLOOD-PRESSURE | COTRANSPORTER 2 INHIBITORS | myocardial infarction | HEART-FAILURE HOSPITALIZATION | stroke | ANGIOTENSIN-CONVERTING ENZYME | PEPTIDE-1 RECEPTOR AGONISTS | BASE-LINE CHARACTERISTICS | ALL-CAUSE MORTALITY | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | mortality | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | TYPE-2 DIABETES-MELLITUS | REG OUTCOME TRIAL | Treatment outcome | Proteases | Analysis | Research | Cardiovascular diseases | Drug therapy | Risk factors | 10060 | 10150 | 10161 | 10072 | 10094 | Reviews | 10099 | 10021 | 10178 | 10189 | 10058
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: A phase 1/2 randomized controlled trial (RIMECARD trial [Randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy])
by Bartolucci, Jorge and Verdugo, Fernando J and González, Paz L and Larrea, Ricardo E and Abarzua, Ema and Goset, Carlos and Rojo, Pamela and Palma, Ivan and Lamich, Ruben and Pedreros, Pablo A and Valdivia, Gloria and Lopez, Valentina M and Nazzal, Carolina and Alcayaga-Miranda, Francisca and Cuenca, Jimena and Brobeck, Matthew J and Patel, Amit N and Figueroa, Fernando E and Khoury, Maroun
Circulation Research, ISSN 0009-7330, 2017, Volume 121, Issue 10, pp. 1192 - 1204
Rationale: Umbilical cord-derived mesenchymal stem cells (UC-MSC) are easily accessible and expanded in vitro, possess distinct properties, and improve... 
Heart failure | Mesenchymal stromal cells | Cardiomyopathies | Clinical trial | Umbilical cord | clinical trial | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | GROWTH-FACTOR GENE | mesenchymal stromal cells | DILATED CARDIOMYOPATHY | SPANISH VERSION | ENDOTHELIAL PROGENITOR CELLS | ISCHEMIC CARDIOMYOPATHY | THERAPY | DOUBLE-BLIND | CANINE HEART | PERIPHERAL VASCULAR DISEASE | umbilical cord | STROMAL CELLS | HEMATOLOGY | cardiomyopathies | BLOOD | Double-Blind Method | Umbilical Cord - transplantation | Humans | Middle Aged | Mesenchymal Stem Cells - physiology | Male | Treatment Outcome | Cell Movement - physiology | Mesenchymal Stem Cell Transplantation - methods | Heart Failure - therapy | Female | Aged | Heart Failure - diagnosis | Infusions, Intravenous | Treatment outcome | Usage | Injections, Intravenous | Safety and security measures | Magnetic resonance imaging | Analysis | Stem cells | Diagnosis | Research | 10019 | 10090 | Clinical Track | 10094 | 10052 | 10021
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon)
by Schroeder, Henrik and Werner, Martin and Meyer, Dirk-Roelfs and Reimer, Peter and Krüger, Karsten and Jaff, Michael R and Brodmann, Marianne and ILLUMENATE EU RCT Investigators
Circulation, ISSN 0009-7322, 06/2017, Volume 135, Issue 23, pp. 2227 - 2236
BACKGROUND:Numerous studies have reported favorable outcomes using drug-coated balloons (DCBs) for treatment of symptomatic peripheral artery disease of the... 
Peripheral artery disease | Drug-eluting balloon | Percutaneous treatment | Randomized controlled trial | Paclitaxel | SWINE MODEL | paclitaxel | CARDIAC & CARDIOVASCULAR SYSTEMS | peripheral artery disease | METAANALYSIS | drug-eluting balloon | EFFICACY | SAFETY | LESIONS | randomized controlled trial | percutaneous treatment | RESTENOSIS | PERIPHERAL VASCULAR DISEASE | NITINOL STENTS | Angioplasty - trends | Single-Blind Method | Femoral Artery - pathology | Peripheral Arterial Disease - surgery | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Coated Materials, Biocompatible - administration & dosage | Europe - epidemiology | Male | Treatment Outcome | Angioplasty - methods | Time Factors | Peripheral Arterial Disease - epidemiology | Peripheral Arterial Disease - diagnostic imaging | Female | Popliteal Artery - surgery | Aged | Popliteal Artery - pathology | Paclitaxel - administration & dosage | Angioplasty, Balloon - trends | Femoral Artery - surgery | Angioplasty, Balloon - methods | 10191 | 10193 | 10195 | 10021 | Original s
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Brain Activity and Cerebral Oxygenation After Perinatal Arterial Ischemic Stroke Are Associated With Neurodevelopment
by Wagenaar, Nienke and van den Berk, Daphne J.M and Lemmers, Petra M.A and van der Aa, Niek E and Dudink, Jeroen and van Bel, Frank and Groenendaal, Floris and de Vries, Linda S and Benders, Manon J.N.L and Alderliesten, Thomas
Stroke, ISSN 0039-2499, 10/2019, Volume 50, Issue 10, pp. 2668 - 2676
BACKGROUND AND PURPOSE—In infants with perinatal arterial ischemic stroke (PAIS), early prognosis of neurodevelopmental outcome is important to adequately... 
developmental disabilities | neonate/newborn | BIRTH ASPHYXIA | PREDICTIVE-VALUE | stroke | hemodynamic monitoring | AMPLITUDE-INTEGRATED EEG | CLINICAL NEUROLOGY | ENCEPHALOPATHY | brain injury | FUNCTION MONITOR | FULL-TERM INFANTS | PERIPHERAL VASCULAR DISEASE | neonatal intensive care | Original Contributions | 10132 | 10176 | 10021 | 10178 | neonate | newborn
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity
by Banerjee, Poulabi and Chan, Kuo-Chen and Tarabocchia, Michel and Benito-Vicente, Asier and Alves, Ana C and Uribe, Kepa B and Bourbon, Mafalda and Skiba, Paul J and Pordy, Robert and Gipe, Daniel A and Gaudet, Daniel and Martin, Cesar
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 11/2019, Volume 39, Issue 11, pp. 2248 - 2260
OBJECTIVE:Homozygous familial hypercholesterolemia is a rare disease usually caused by LDLR (low-density lipoprotein receptor) mutations. Homozygous familial... 
proof of concept study | rare disease | TRANSMEMBRANE DOMAIN | PCSK9 | MONOCLONAL-ANTIBODY | hypercholesterolemia | mutations | INHIBITION | GENE | DOUBLE-BLIND | ANGPTL3 | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | EVOLOCUMAB | lipoproteins | AMG 145 | 10021 | 10034 | 10188 | 10014 | 10058 | Basic Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Pregnancy-Related Acute Kidney Injury in Preeclampsia: Risk Factors and Renal Outcomes
by Conti-Ramsden, Frances I and Nathan, Hannah L and De greeff, Annemarie and Hall, David R and Seed, Paul T and Chappell, Lucy C and Shennan, Andrew H and Bramham, K
Hypertension, ISSN 0194-911X, 11/2019, Volume 74, Issue 5, pp. 1144 - 1151
Preeclampsia is a common cause of acute kidney injury (AKI) in low- and middle-income countries, but AKI incidence in preeclampsia, its risk factors, and renal... 
POPULATION | renal insufficiency | pregnancy | preeclampsia | FAILURE | GLOMERULAR-FILTRATION-RATE | RECOVERY | creatinine | DISEASE | PERIPHERAL VASCULAR DISEASE | acute kidney injury | chronic | AKI | renal insufficiency, chronic | 10021 | 10112 | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights